Drug intelligence / Profile preview

Norbeepee

Development stage: Unknown
Lead developer: AVN Ayurveda Formulations
Administration: Oral

Overview

**Norbeepee** is a proprietary polyherbal Ayurvedic tablet marketed by AVN Ayurveda Formulations for the management of hypertension. Each 200 mg tablet contains Vacha (*Acorus calamus*), Pushkaramula (*Inula racemosa*), Usira (*Vetiveria zizanioides*), Daruharidra (*Berberis aristata*), and Sarpagandha (*Rauwolfia serpentina*), each at 40 mg. AVN describes the formulation as having sympatholytic, peripheral vasodilatory, diuretic, and anxiolytic effects; its proposed antihypertensive activity is therefore based on combined botanical actions rather than a defined single molecular target. ([avnayurveda.com](https://www.avnayurveda.com/product/norbeepee-tablets/))

Brand names: Norbeepee
Other names: Norbeepee Tablets

Beyond the preview

Go deeper on Norbeepee.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norbeepee.

Explore the full profile